FGCZ Innovation Seminar
Spatial and Single Cell Metabolomics in the Age of AI
Theodore Alexandrov Assistant Professor, Departments of Pharmacology and Bioengineering, UC San Diego Founder of METASPACE
Bishoy Wadie Lead Data Scientist, METASPACE
When: Wednesday 25.11.2026, 16:00–17:15, followed by an apéro
Where: Functional Genomics Center Zurich UZH Irchel Campus, Y59 G30 Winterthurerstrasse 190, 8057 Zurich
Language: English
Host: Dr. Alaa Othman, Metabolomics Unit, FGCZ
Why spatial and single-cell metabolomics
Metabolites and lipids are the molecules closest to what a cell is actually doing. Classical metabolomics measures them in an extract, which averages millions of cells and loses two things: where in the tissue a molecule was, and which cells it came from.
Spatial metabolomics keeps that information. Imaging mass spectrometry measures hundreds of metabolites and lipids directly in a tissue section, pixel by pixel and without labels, so that metabolism can be read next to the histology: a tumor and its microenvironment, the zones of a liver lobule, the layers of a brain region, or where a drug and its metabolites end up.
Single-cell metabolomics goes a step further by assigning metabolic profiles to individual cells. Cells that look identical under the microscope can be in different metabolic states, and that difference is invisible in a bulk measurement.
Every step matters. How the tissue is collected and frozen, how it is sectioned, how the matrix is sprayed, and how the data are acquired all change what ends up in the image, so quality control and standard procedures matter as much as the instrument. Then comes interpretation: one imaging dataset holds thousands of ion images, and metabolites, unlike genes, cannot be amplified or read from a sequence, so every signal has to be assigned to a molecule. This is where computation, machine learning and AI come in, for annotating molecules with a controlled error rate, for linking metabolic images to cell types, and for learning from the many thousands of public datasets that the community has shared.
About the FGCZ Innovation Seminar
With the Innovation Seminar series, the FGCZ brings new developments in the omics fields to its users. We invite the people who build the methods to explain where their field stands, what works today and what is still open, so that researchers in Zurich can judge for themselves what it could mean for their own work. The apéro afterwards is the place for questions and discussion with the speakers.
About the speakers and METASPACE
METASPACE is an open cloud platform for annotating metabolites and lipids in imaging mass spectrometry data. Researchers upload a dataset and receive molecular annotations with a controlled false discovery rate, and the public datasets on the platform form a community knowledge base of spatial metabolomics.
Theodore Alexandrov is an Assistant Professor in the Departments of Pharmacology and Bioengineering at the University of California, San Diego. He previously led a team at the European Molecular Biology Laboratory (EMBL), where he established and directed the EMBL Metabolomics Core Facility. At UCSD he leads a team of scientists and software engineers developing technologies for spatial and single-cell metabolomics. He developed METASPACE and SpaceM, a method for spatial single-cell metabolomics, co-founded SCiLS, and in 2025 co-founded the biotech startup DeepCyte.
Bishoy Wadie is the lead data scientist of METASPACE.
The seminar is followed by an apéro, with time to talk to the speakers.